Suchergebnisse - "Chronic myelogenous leukemia"

PubPharm (1.821)

1

The Effect and Safety of Flumatinib in Patients with Chronic Myelogenous Leukemia Failed First-and Second-line Treatment

enthalten in: Zhongguo shi yan xue ye xue za zhi | 2024

von Liu, L. | Wei, J. | Jia, T. | +2

2

The molecular basis of Abelson kinase regulation by its αI-helix

enthalten in: eLife | 2024

von Paladini, J. | Maier, A. | Habazettl, J. | +3

3

Impact of initiating oral anticancer agents for leukemia on adherence to medications for multiple chronic conditions

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2024

von Gatwood, J. | Dashputre, A. | Rajpurohit, A. | +6

4

Zinc as a potential regulator of the BCR-ABL oncogene in chronic myelocytic leukemia cells

enthalten in: Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) | 2024

von Zhu, B. | Sun, L. | Li, Z. | +6

5

Inhibition of LATS kinases reduces tumorigenicity and increases the sensitivity of human chronic myelogenous leukemia cells to imatinib

enthalten in: Scientific reports | 2024

von Klaihmon, P. | Lorthongpanich, C. | Kheolamai, P. | +2

6

Chemoproteomics Reveals Glaucocalyxin A Induces Mitochondria-Dependent Apoptosis of Leukemia Cells via Covalently Binding to VDAC1

enthalten in: Advanced biology | 2024

von An, Y. | Zhang, Q. | Chen, Y. | +8

7

AS1041, a novel derivative of marine natural compound Aspergiolide A, induces senescence of leukemia cells via oxidative stress-induced DNA damage and BCR-ABL degradation

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2024

von Lu, X. | Yuan, F. | Qiao, L. | +6

8

Properties of FDA-approved small molecule protein kinase inhibitors : A 2024 update

enthalten in: Pharmacological research | 2024

von Roskoski, R.

9

Correlation analysis of bone marrow microvessel density and miRNA expression on drug resistance in patients with chronic myelogenous leukemia after tyrosine kinase inhibitor treatment

enthalten in: Hematology (Amsterdam, Netherlands) | 2024

von Guo, Y. | Zhang, L. | Hu, P. | +6

10

A label free chemoproteomic-based platform to disclose cannabidiol molecular mechanism of action on chronic myelogenous leukemia cancer cells

enthalten in: Heliyon | 2024

von Ceccacci, S. | Corsi, L. | Spinelli, L. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[183]